Cannabis producer Althea Group’s Share Price Rises on expansion deal

By ,

Shares in Althea Group Holdings Ltd [ASX:AGH] have risen on the news that the Australian company will supply its range of products to the UK’s first national pilot study for medical cannabis.

At time of writing Althea Group’s share price at sitting $1.08, up 6.97%.

Althea Group is a licensed producer which supplies pharmaceutical grade cannabis for patients with debilitating conditions.

Related: Download your free report to learn four of the hottest pot stocks on the ASX right now.

Project TWENTY21

The pilot scheme, which aims to enrol 20,000 patients by 2021, will target a number of chronic conditions and diseases in which previous alternative treatments have had limited efficacy, including PTSD, anxiety, multiple sclerosis, Tourette’s syndrome and chronic pain.

The study will use a real-world data registry to ‘assess efficacy, safety and patient-reported outcomes’ through prescribed medical cannabis use.

Althea Group, which will oversee the trial alongside Drug Science (an independent scientific committee based in the UK), will use the pilot as part of its strategy to enhance its global reputation as a medical cannabis supplier.

The company has high hopes for the value of the public study, saying:

We believe the pilot program will yield valuable data that can be used to further bolster the case for wider medicinal cannabis use and inform public health and stakeholder decisions.’

Milestones for Althea Group

The emerging UK market has significant potential for Althea Group, with an estimated treatable population of 2.9 million patients available.

Their participation in Project TWENTY21 further cements the company’s plan to make a European expansion, with patient prescription trials in the UK only the beginning.

Althea Group is quickly turning into a stock to watch, with more than 1,000 patients now using Althea’s products.

Confidence in the market looks to continue, with the company expecting that number to increase by 200 patients by June’s end.

More to come.

Regards,

Ryan Clarkson-Ledward

For Money Morning

PS: In a brand-new report titled ‘Top Four Pot Stocks for 2019’, we reveal the pot players dominating the local and global markets for legal marijuana. Download it here to find out more.

About Ryan Clarkson-Ledward

Ryan Clarkson-Ledward is an Editor at Money Morning.

Ryan holds degrees in both communication and international business. He helps bring Money Morning readers the latest market updates, both locally and abroad. Ryan tackles all the issues investors need to know about that the mainstream media neglects.

Ryan is also the Editor…

Althea Group’s Results Show the Cannabis Boom Is Building Momentum

The share price of cannabis products producer and distributor Althea Group Holding Ltd [ASX:AGH] has surged as its first-half revenue nearly triples. At time of writing AGH shares are up 5.66% to trade at 56 cent per share…

Althea Share Price Up on First Germany Shipment (ASX:AGH)

At time of writing, the share price of Althea Group Holdings Ltd [ASX:AGH] is up 10%, trading at 55 cents…

Althea Group Shares Rise as Cannabis Sales Deliver Record Revenues

It’s been another big day for pot stocks. With the sector enjoying a surge of late. Althea Group Holdings Ltd [ASX:AGH] is the big winner. With its share price trading 2.75% higher at time of writing — thanks to some impressive sales results…

Althea Group Share Price Up Again on New Deal (ASX:AGH)

he share price of Althea Group Holdings Ltd [ASX:AGH] jumped up 7.22% at time of writing to trade at 52 cents. The company announced a new manufacturing and distribution deal for cannabis-infused beverages in Canada…

Althea Group Share Price Up on Germany Expansion (ASX:AGH)

At time of writing, the share price of Althea Group Holdings Ltd [ASX:AGH] is up 3.19%, trading at 48.5 cents. The AGH share price got a lift today on the announcement of an expansion into Germany. Medical cannabis is booming…

AGH Shares Up on Revenue Guidance, Pot Stocks Making a Comeback?

Shares in Althea Group Holdings Ltd [ASX:AGH] have rebounded today upon the release of updated revenue guidance. Pot stocks have been on a steady decline since coming off their peak in late 2018, although they now appear to be making a resurgence…